
Carl Otto Lange
We are a Nordic law firm with a simple business concept : to create value for you. This is the guiding principle in everything we do. This means that we always look for solutions which not only comply with the law, but which also generate commercial advantages. It also means that it's not enough for us to obtain results. We want good results. Irrespective of the industry. Irrespective of which Nordic country is involved. Cross-border.
The business operations conducted within life science companies often involve major risks and opportunities for significant earnings. The risks come not only from the advanced scientific and supervisory environment but also from complicated business models. A key to success is for companies to be able to handle these risks. This demands that the contracts which are produced exhaustively govern all of the risks and that these risks are appropriately allocated between the parties.
NORDIA has a practice group with lawyers experienced in life science to assist national and international companies in the area, both listed companies and private companies.
Nordia Law
Lawyer, advokat
Björn Larsson
GU Holding is a company owned by the Swedish government. Its mission is to provide funds and business competence for new companies to ensure growth of value and development of companies based on top-notch academic competence and research within University of Gothenburg.
The business concept consists of supplying project and start-up capital together with business competency to add value to and efficiently develop new businesses based on academic leading edge competency and research results. The aim is to create successful growth companies. All projects must be commercially viable, and business ideas and inventions must meet high standards.
GU Holding's mission is to contribute to the development of University of Gothenburg, its staff as well as the whole of the Västra Götaland region. There is close cooperation between the university, including all pursued disciplines, and its various bodies dealing with commercialisation, such as GU Research and Innovation Services.
GU Holding works together with Research and innovationservice at University of Gothenburg. Further, GU Holding has close contact with other innovation actors, such as The Innovation Bridge, Sahlgrenska Science Park, Vinnova, Innovationskontor Väst, Västra Götaland Region and Tillväxtverket as well as business entrepreneurs, private actors within trade and industry or on the capital market, for instance highly esteemed venture capitalists.
The portfolio of GU Holding consists of 33 newly build companies and 14 business projects in many different areas.
GU Holding has invested in pain relief, speaking computers, customized back-in counters, security, oyster farming, a cure for kidney cancer and fish feed ingredient to name a few.

Mr Thomas Larsson
Experts in all areas related to solid state characterization of pharmaceutical material. Unique knowledge related to development of Dry Powder Inhalation products, but cover also oral product development area.

Miss Maria Lennerås
TATAA Biocenter is Europe’s leading provider of gene expression profiling services and a prime organizer of hands-on training in quantitative real-time PCR (qPCR).
Frost & Sullivan presents TATAA Biocenter with the 2013 European Frost & Sullivan Award for customer value leadership.
TATAA is one of the first laboratories to have obtained ISO/IEC 17025:2005 flexible certification for qPCR analysis in Europe.
Dr Mikael Lindstam
Forskarpatent specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. At present Forskarpatent holds a portfolio of 15 different projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets.
Innovationspatent
Portfolio ManagerProfessor Lennart Lundberg
Company: LipUm AB, Umeå, Sweden (Susanne Lindquist, Olle Hernell and Lennart Lundberg)
LipUm AB´s goal is to develop a novel biological anti-inflammatory therapy with the protein BSSL (Bile Salt-Stimulated Lipase) as target.
LipUm AB
VP IP and BDMr Torbjörn Lundh
PressCise is a research project from CHalmers and University of Gothenburg aimed at developing a unique bandage. The bandage will be used for remediation including varicose vein surgery and should be easy to wrap.

Mrs Gertrud Lundkvist
ClinTrials Skåne is a public limited company dedicated to helping the life science industry developing their products in close cooperation with universities and the public health care sector in the county of Skåne. We have long experience in working with clinical trials and product development in hospitals in Skåne. Our offices are located in Skåne university hospital and in Medicon Village in Lund, with direct access to both the life science industry and the public healthcare system.